Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06238414 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Attempted Suicide Intervention Treatment and Prevention (SAMIT Program)

Study acronym: SAMIT
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date changed from estimate of Jun 30, 2025 to Apr 19, 2026v4 Show 5 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 120 to confirmed 75
    • Study completion date: Apr 27, 2026 to Dec 31, 2026
    • Study description expanded, about 83 words
    • Site details revised
  2. Minor Eligibility criteria revised
    • Secondary endpoints: 16 to 17
    v3
  3. Minor Eligibility criteria revised
    • Secondary endpoints: 15 to 16
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Suicide has become a first-order public health concern after the negative impact of coronavirus disease 2019 (COVID-19) on the mental health of the general population. Few studies have analyzed the effects of early psychotherapeutic interventions on subjects who have attempted suicide, and even fewer focus on those hospitalized in nonpsychiatric units after a medically serious suicide attempt (MSSA). The most important risk factor for attempting suicide is having made a previous suicide attempt. Subjects are also at higher risk the first year after the attempt. The main aim of this study is to evaluate the effectiveness of individual psychological treatment with patients hospitalized after a MSSA. The secondary objectives are: 1) acknowledge the evolution of the incidence of MSSA hospitalized during the pandemic; 2) analyze the impact of the psychological intervention using biological, psychosocial, and clinical variables. An experimental, controlled, and randomized trial will be conducted with patients older than 16 admitted to two general hospitals. The case group will receive an 8- session of individual psychotherapy while the control group received treatment as usual. Longitudinal assessment will be conducted at baseline, post-treatment, and 3, 6, and 12 months after. The main outcome variable will be re-attempting suicide during the follow-up.
Trial Details
NCT Number NCT06238414
Lead Sponsor Hospital Universitari Vall d'Hebron Research Institute
Collaborators: Hospital Clinic of Barcelona
Conditions
(from sponsor)
Suicide, Attempted, Suicide Prevention
Related terms Suicide Prevention, Suicide, Attempted
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov